Neurological examination revealed improvement in all neurological indices analysed in a percentage of patients ranging from 11.9% (muscular trophism) to 29.1% (topographic score)
The Evidence: Randomized placebo-controlled studies demonstrate that Transcranial PBM significantly reduces the number of headache days per month by raising the brain's metabolic threshold and reducing cortical hyperexcitability [5]
They do not diagnose, treat, cure, or prevent disease and should not replace care from your physician
References Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF
In corneal epithelial cells, TB-500 could potentially inhibit apoptosis by blocking caspases and curtailing the release of the pro-apoptotic protein bcl-2 from mitochondria